Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth M Swisher

Showing results (61-70 of 194) with videos related to

Pageof 20
Sort By:
Cell Reports|April 5, 2018
Multifaceted Impact of MicroRNA 493-5p on Genome-Stabilizing Pathways Induces Platinum and PARP Inhibitor Resistance in BRCA2-Mutated CarcinomasKhyati Meghani, Walker Fuchs, Alexandre Detappe, et al.
Gynecologic Oncology|September 2, 2008
DNA hypermethylation, Her-2/neu overexpression and p53 mutations in ovarian carcinomaQinghua Feng, Georgios Deftereos, Stephen E Hawes, et al.
Cancer Research|August 6, 2009
Functional restoration of BRCA2 protein by secondary BRCA2 mutations in BRCA2-mutated ovarian carcinomaWataru Sakai, Elizabeth M Swisher, Céline Jacquemont, et al.
Gynecologic Oncology|February 8, 2008
An evaluation of cervical cancer in women age sixty and overKatrina V Fox, Chirag A Shah, Elizabeth M Swisher, et al.
Gynecologic Oncology|December 19, 2012
53BP1 expression in sporadic and inherited ovarian carcinoma: Relationship to genetic status and clinical outcomesKathryn P Pennington, Anneka Wickramanayake, Barbara M Norquist, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 29, 2002
BRCA1 transcriptionally regulates genes involved in breast tumorigenesisPiri L Welcsh, Ming K Lee, Rachel M Gonzalez-Hernandez, et al.
Cold Spring Harbor Molecular Case Studies|April 9, 2021
Long-term survival of an ovarian cancer patient harboring a RAD51C missense mutationMeghan R Sullivan, Rohit Prakash, Yashpal Rawal, et al.
Cancer Research|December 12, 2019
Rare <i>BRIP1</i> Missense Alleles Confer Risk for Ovarian and Breast CancerCassandra L Moyer, Jennifer Ivanovich, Jessica L Gillespie, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|December 5, 2014
Characterization of precursor lesions in the endometrium and fallopian tube epithelium of early-stage uterine serous carcinomaMary C Tolcher, Elizabeth M Swisher, Fabiola Medeiros, et al.
Cancer|July 29, 2010
The molecular pathogenesis of hereditary ovarian carcinoma: alterations in the tubal epithelium of women with BRCA1 and BRCA2 mutationsBarbara M Norquist, Rochelle L Garcia, Kimberly H Allison, et al.
Pageof 20

Showing results (61-70 of 194) with videos related to

Sort By:
Pageof 20
Cell Reports|April 5, 2018
Multifaceted Impact of MicroRNA 493-5p on Genome-Stabilizing Pathways Induces Platinum and PARP Inhibitor Resistance in BRCA2-Mutated CarcinomasKhyati Meghani, Walker Fuchs, Alexandre Detappe, et al.
Gynecologic Oncology|September 2, 2008
DNA hypermethylation, Her-2/neu overexpression and p53 mutations in ovarian carcinomaQinghua Feng, Georgios Deftereos, Stephen E Hawes, et al.
Cancer Research|August 6, 2009
Functional restoration of BRCA2 protein by secondary BRCA2 mutations in BRCA2-mutated ovarian carcinomaWataru Sakai, Elizabeth M Swisher, Céline Jacquemont, et al.
Gynecologic Oncology|February 8, 2008
An evaluation of cervical cancer in women age sixty and overKatrina V Fox, Chirag A Shah, Elizabeth M Swisher, et al.
Gynecologic Oncology|December 19, 2012
53BP1 expression in sporadic and inherited ovarian carcinoma: Relationship to genetic status and clinical outcomesKathryn P Pennington, Anneka Wickramanayake, Barbara M Norquist, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 29, 2002
BRCA1 transcriptionally regulates genes involved in breast tumorigenesisPiri L Welcsh, Ming K Lee, Rachel M Gonzalez-Hernandez, et al.
Cold Spring Harbor Molecular Case Studies|April 9, 2021
Long-term survival of an ovarian cancer patient harboring a RAD51C missense mutationMeghan R Sullivan, Rohit Prakash, Yashpal Rawal, et al.
Cancer Research|December 12, 2019
Rare <i>BRIP1</i> Missense Alleles Confer Risk for Ovarian and Breast CancerCassandra L Moyer, Jennifer Ivanovich, Jessica L Gillespie, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|December 5, 2014
Characterization of precursor lesions in the endometrium and fallopian tube epithelium of early-stage uterine serous carcinomaMary C Tolcher, Elizabeth M Swisher, Fabiola Medeiros, et al.
Cancer|July 29, 2010
The molecular pathogenesis of hereditary ovarian carcinoma: alterations in the tubal epithelium of women with BRCA1 and BRCA2 mutationsBarbara M Norquist, Rochelle L Garcia, Kimberly H Allison, et al.
Pageof 20